系统综述与荟萃分析:新辅助治疗后胰腺导管腺癌可切除性评估的CT诊断效能
该系统综述与荟萃分析纳入10项研究,评估CT在新辅助治疗后胰腺导管腺癌可切除性判断中的诊断效能,汇总敏感度为78%、特异度为60%。不同CT标准显著影响诊断效能,改良标准较传统标准敏感度更高(81% vs. 28%)但特异度更低(57% vs. 90%)。
要点
- 新辅助治疗后PDAC可切除性评估的CT汇总敏感度78%、特异度60%,特异度偏低需警惕过度判断可切除。
- 所用CT可切除标准是影响诊断效能的关键因素,阅片与报告应明确所采用的标准。
- 改良标准提高敏感度但降低特异度,目前仍需进一步改良以兼顾特异度与标准统一性。
核心结论
- CT可切除性标准是影响新辅助治疗后PDAC可切除性诊断效能的因素,改良传统标准可提高敏感度但降低特异度,仍需进一步改良以提升特异度与标准统一性。
研究设计与样本
- 由两名评价者独立提取数据并评估研究质量,采用双变量随机效应模型汇总敏感度与特异度,并评估研究间异质性。
- 采用单变量荟萃回归分析8个变量,包括不同的CT可切除性标准、用于初始手术的传统NCCN标准及新辅助术后改良标准。
诊断标准与关键数值
- 可切除性判断的汇总敏感度为78%(95% CI 68-86%),汇总特异度为60%(95% CI 44-74%)。
- 两种不同CT标准间诊断效能差异有统计学意义(p < 0.01)。
- 改良标准的敏感度为81%(95% CI 73-90%),高于传统标准的28%(95% CI 15-42%),差异有统计学意义(p < 0.01)。
- 改良标准的特异度为57%(95% CI 41-73%),低于传统标准的90%(95% CI 80-100%),差异有统计学意义(p < 0.01)。
临床应用与阅片要点
- 阅片判断新辅助治疗后PDAC可切除性时,应在报告中注明所依据的CT可切除性标准,便于临床解读。
- 采用敏感度较高的改良标准时需注意特异度下降,对边界可切除征象应谨慎表述以避免假阳性。
- 常规NCCN初始手术标准用于新辅助治疗后评估时敏感度低,直接套用可能低估可切除性。
局限性
- 纳入研究仅10项,证据基础有限。
- 不同研究采用的CT可切除性标准不一致,是影响诊断效能的主要异质性来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the CT diagnostic performance for evaluating resectability of pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant therapy and identify the factor(s) that affect(s) diagnostic performance.
METHODS: Databases were searched to identify studies published from January 1, 2000, to November 5, 2019 that evaluated the CT diagnostic performance for assessing resectability of post-neoadjuvant PDAC. Two reviewers independently extracted data and assessed the study quality. A meta-analysis was performed to obtain summary sensitivity and specificity values using a bivariate random-effects model, and heterogeneity across studies was assessed. Univariable meta-regression analysis was performed with eight variables, including the different CT criteria for resectability, conventional National Comprehensive Cancer Network (NCCN) criteria for upfront surgery, and modified criteria for post-neoadjuvant surgery.
RESULTS: Ten studies were included and analyzed. The summary sensitivity and specificity for resectability were 78% (95% CI 68-86%) and 60% (95% CI 44-74%), respectively. No significant heterogeneity was identified (bivariate correlation coefficient ρ = - 1, p-value for hierarchical summary receiver operating characteristics model β = 0.667). The two different CT criteria showed different diagnostic performance (p < 0.01), with higher sensitivity (81% [95% CI 73-90%] vs. 28% [95% CI 15-42%], p < 0.01) and lower specificity (57% [95% CI 41-73%] vs. 90% [95% CI 80-100%], p < 0.01) for the modified criteria. No other variables affected the diagnostic performance.
CONCLUSION: CT criteria were the factors that affected the diagnostic performance. Modification of the conventional criteria improved sensitivity but lowered specificity. Further modifications are required to improve specificity and uniformity.
引用
- Yang HK, Park MS, Choi M, et al. Systematic review and meta-analysis of diagnostic performance of CT imaging for assessing resectability of pancreatic ductal adenocarcinoma after neoadjuvant therapy: importance of CT criteria. Abdom Radiol (NY). 2021. PMID: 34331549. doi:10.1007/s00261-021-03198-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。